These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19946296)

  • 1. Metabolic bone diseases: treating Paget disease: when matters more than how.
    Brown JP
    Nat Rev Rheumatol; 2009 Dec; 5(12):663-5. PubMed ID: 19946296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optimizing therapy in Paget disease].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):32. PubMed ID: 16402704
    [No Abstract]   [Full Text] [Related]  

  • 3. Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
    Pane A
    Arch Ophthalmol; 2007 Oct; 125(10):1440-1. PubMed ID: 17923566
    [No Abstract]   [Full Text] [Related]  

  • 4. A classical presentation of Paget disease of bone.
    Sheane BJ; Delaney H; Doran MF; Cunnane G
    J Clin Rheumatol; 2008 Dec; 14(6):373. PubMed ID: 19060670
    [No Abstract]   [Full Text] [Related]  

  • 5. Paget disease of bone - an update.
    Britton C; Walsh J
    Aust Fam Physician; 2012 Mar; 41(3):100-3. PubMed ID: 22396921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice. Paget's disease of bone.
    Ralston SH
    N Engl J Med; 2013 Feb; 368(7):644-50. PubMed ID: 23406029
    [No Abstract]   [Full Text] [Related]  

  • 7. Paget disease of bone: diagnosis and drug therapy.
    Seton M
    Cleve Clin J Med; 2013 Jul; 80(7):452-62. PubMed ID: 23821690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A; Rotés Sala D; Almirall Bernabé M; Carbonell Abelló J
    Med Clin (Barc); 2006 Oct; 127(16):635-6. PubMed ID: 17145033
    [No Abstract]   [Full Text] [Related]  

  • 9. Paget disease of the patella in a patient presenting with anterior knee pain.
    Olubaniyi BO; Howlett DC
    J Clin Rheumatol; 2014 Sep; 20(6):337. PubMed ID: 25160022
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical practice. Paget's disease of bone.
    Whyte MP
    N Engl J Med; 2006 Aug; 355(6):593-600. PubMed ID: 16899779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paget's disease of bone].
    Holgado Pérez S; Sallés Lizarzáburu M; Olivé Marqués A
    Med Clin (Barc); 2008 Oct; 131(13):509-12. PubMed ID: 19007581
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of zoledronic acid treatment in Paget disease of bone.
    Baykan EK; Saygılı LF; Erdogan M; Cetinkalp S; Ozgen AG; Yilmaz C
    Osteoporos Int; 2014 Sep; 25(9):2221-3. PubMed ID: 24899102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates.
    Reid IR
    Skeletal Radiol; 2007 Aug; 36(8):711-4. PubMed ID: 17340165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Questions and answers about bisphosphonates].
    Letonturier P
    Presse Med; 2007 Mar; 36(3 Pt 1):440. PubMed ID: 17436449
    [No Abstract]   [Full Text] [Related]  

  • 15. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.
    Reid IR; Lyles K; Su G; Brown JP; Walsh JP; del Pino-Montes J; Miller PD; Fraser WD; Cafoncelli S; Bucci-Rechtweg C; Hosking DJ
    J Bone Miner Res; 2011 Sep; 26(9):2261-70. PubMed ID: 21638319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to publication of PRISM trial.
    Reid IR; Cundy T; Bolland MJ; Grey A
    J Bone Miner Res; 2010 Jun; 25(6):1463-4; author reply 1465-6. PubMed ID: 20499373
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
    Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging issues with bisphosphonates.
    Reid IR
    Rheum Dis Clin North Am; 2006 Nov; 32(4):691-702, vi. PubMed ID: 17288972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D; Martínez-Morillo M; Holgado S; Erra A
    Med Clin (Barc); 2014 May; 142(10):469-70. PubMed ID: 24120108
    [No Abstract]   [Full Text] [Related]  

  • 20. Paget's disease. Common cause of bone weakening.
    Mayo Clin Health Lett; 2013 Jun; 31(6):7. PubMed ID: 24716278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.